The National Service Framework on coronary heart disease: is it sufficiently evidence-based?
Ferns
G A
GA
Centre for Clinical Science and Measurement, School of Biomedical anld Life Science, University of Surrey, Guildford, UK. g.ferns@surrey.ac.uk
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000175:diagnosis* / Q000517:prevention & control* / Q000628:therapy*; D003695:Delivery of Health Care / Q000191:economics* / Q000592:standards*; D019317:Evidence-Based Medicine; D006801:Humans; D008148:Lovastatin / Q000627:therapeutic use; D010641:Phenotype; D006113:United Kingdom
D000924:Anticholesteremic Agents; D008148:Lovastatin